Presentaciones científicas

Año	Trabajo presentado	Tipo
2021	Rapid and efficient method to generate a polyclonal suspension of autoimmune lymphocytes from mononuclear cells from healthy and autoimmune diseased individuals International Society for Cell & Gene Therapy (ISCT) 2023, May 30- June 3, 2023 Paris, France. Website:	Presentación oral
2021	Long term evolution after Cellular therapy in Spinal Cord Injury patients 13th International Association of Neurorestoratology (IANR) Conference, 26-28 May, 2021 Warsaw, Poland. Website: - Video:	Presentación oral
2021	Phenotypic Changes observed on tissue specific EC during activation, and on aMSC after the co-culture of it with the activated EC 13th International Association of Neurorestoratology (IANR) Conference, 26-28 May, 2021 Warsaw, Poland. Website: - Video:	Presentación oral
2019	Efficiency and effectiveness of combined cell therapy in previously chronic and complete Spinal Cord Injury subjects 12th International Association of Neurorestoratology (IANR) Conference, 2-5 October, 2019 Amman, Jordan. Website:	Presentación oral
2018	Brain injury neurorestoration 11th International Association of Neurorestoratology (IANR) Conference, 2-4 October, 2018 at Rutgers University in Piscataway, New Jersey USA. Website:	Presentación oral
2018	Efficiency and effectiveness of combined cell therapy in Spinal Cord Injury patients 11th International Association of Neurorestoratology (IANR) Conference, 2-4 October, 2018 at Rutgers University in Piscataway, New Jersey USA. Website:	Presentación oral
2017	Combined cellular therapy to restore retinal structural pathology XXIII World Congress of Neurology (WCN 2017), Kyoto, Japan \| September 16-21, 2017 Website: - Publication: Combined cellular therapy to restore retinal structural pathology	Presentación sesión Poster
2017	Expanded autologous UCB MSC associated to mother effector T cells against brain antigens and autologous neural progenitor cells (npc) to revert brain injury. Case report XXIII World Congress of Neurology (WCN 2017), Kyoto, Japan \| September 16-21, 2017. Website: - Publication: Expanded autologous UCB MSC associated to mother effector t cells against brain antigens and autologous neural progenitor cells (NPC) to revert brain injury	Presentación sesión Poster
2017	Recover of voluntary muscular contractile capacity in spinal cord injury patients who received combined autologous stem cell therapy: in spinal cord and skeletal muscle XXIII World Congress of Neurology (WCN 2017), Kyoto, Japan \| September 16-21, 2017. Website: - Publication: FREE PAPERS: STEM CELLS AND GENE THERAPY	Presentación oral
2017	Muscular Trophism and voluntary contractile capacity improvement after intramuscular implant of autologous muscular progenitor cells in SCI patients America Spinal Injury Association’s 2017 Annual Scientific Meeting, April 26-29, Albuquerque in Albuquerque, New Mexico. Website: - Publication:	Presentación sesión Poster
2016	Combined treatment: cellular therapy and rehabilitation for chronic SCI patients. Final results phase I-II clinical trial The 55th ISCoS Annual Scientific Meeting, 14th - 16th September 2016, Vienna, Austria. Website: - Publication: Combined treatment: cellular therapy and rehabilitation for chronic SCI patients	Presentación sesión Poster
2016	Intramuscular cell implant in muscles with electromyography recovery in SCI patients previously treated with neural progenitor cells and intensive rehabilitation The 55th ISCoS Annual Scientific Meeting, 14th - 16th September 2016, Vienna, Austria. Website: - Publication: Intramuscular cell implant in muscles with electromyography recovery in SCI patients	Presentación oral
2016	Results of a Nobel Neurorehabilitation program applied in 8 chronic and complete SCI patients treated with Autologous neural stem cell 10th Congress of International Physical and Rehabilitation Medicine (ISPRM) May 29th- June 2nd 2016; Kuala Lumpur, Malaysia. Website:	Presentación oral
2016	Use of electromyography to evaluate recovery in patients with chronic and complete spinal cord injury who received combined therapy: Neurorehabilitation and Autologous Neural Stem Cell implant 1er Congrés National de Neurophysiologie à la Faculté de Medecine et de Pharmacie de Marrakech, March 18-19. Programa	Presentación oral
2016	Outcomes in 8 chronic and complete spinal cord injury patients after 30 months of combined therapy: neurorehabilitation and autologous neural stem cell implant America Spinal Injury Association’s 2017 Annual Scientific Meeting, April 26-29, Albuquerque in Albuquerque, New Mexico. Website:	Presentación sesión Poster
2015	Electromyographic changes observed after combined treatment: autologous stem cell implant and intensive rehabilitation in patients with complete, chronic SCI XXIIWorld Congress of Neurology (WCN 2015) Santiago, Chile - October 31 – November 5. Website: - Publication: Late Breaking Abstract Session 1 Electromyographic changes observed after combined treatment	Presentación oral
2014	Combined cell therapy for complete chronic Spinal Cord Injury (cSCI) patients. Response after one year of treatment The 53rd ISCOS annual scientific meeting Maastricht, 2-4 September 2014. Website: - Publication: Combined cell therapy for complete chronic Spinal Cord Injury (cSCI) patients	Presentación oral
2014	Adipose Mesenquimal stromal Cells as a base of combined cell therapy for chronic spinal cord injury patients. Clinical ALD electrophysiological response after six month of treatment The 53rd ISCOS annual scientific meeting Maastricht, 2-4 September 2014. Website: - Publication:	Presentación sesión Poster
2013	Surface Electromyography study of complete Spinal Cord Injury Patients. Preliminary Results WCN, XXI World Congress of Neurology, Vienna, Austria. Website: - Publication:	Presentación sesión Poster
2012	Neurorehabilitation after cellular therapy for chronic spinal cord injury patients. 16th Congress of the European Federation of Neurological Societies WCN, XXI World Congress of Neurology, Vienna, Austria. Website: - Publication: Neurorehabilitation after cellular therapy for chronic spinal cord injury patients	Presentación sesión Poster
2011	Functional changes in patient with Transverse Myelitis of 20 years of evolution alter administering combined therapy: autologous neuroblasts implant and intensive neurorehabilitation. Maimónides University, Buenos Aires- Argentina 15th Congress of the European Federation of Neurological Societies, Budapest, Hungary, September 10-13, 2011. Website: - Publication:	Presentación sesión Poster
2007	Minimal Invasive Neural Stem Cell (NSC) Implant Associated with Autologous Effector T Cell (ETC) Treatment for Spinal Cord Injury (SCI) Patients 113º Encuentro Anual de la “International Society for Cellular Therapy”, 24 al 27 Junio, 2007, Sydney, Australia. Website:	Presentación sesión Poster
2007	Effect of Minimal Invasive Neural Stem Cell (NSC) Implant Associated with Autologous Effector T Cell (ETC) Treatment on Severe Brain Injured (BI) Patients 13º Encuentro Anual de la “International Society for Cellular Therapy”, 24 al 27 Junio, 2007, Sydney, Australia. Website:	Presentación sesión Poster

Presentaciones científicas

Rapid and efficient method to generate a polyclonal suspension of autoimmune lymphocytes from mononuclear cells from healthy and autoimmune diseased individuals

Long term evolution after Cellular therapy in Spinal Cord Injury patients

Phenotypic Changes observed on tissue specific EC during activation, and on aMSC after the co-culture of it with the activated EC

Efficiency and effectiveness of combined cell therapy in previously chronic and complete Spinal Cord Injury subjects

Brain injury neurorestoration

Efficiency and effectiveness of combined cell therapy in Spinal Cord Injury patients

Combined cellular therapy to restore retinal structural pathology

Expanded autologous UCB MSC associated to mother effector T cells against brain antigens and autologous neural progenitor cells (npc) to revert brain injury. Case report

Recover of voluntary muscular contractile capacity in spinal cord injury patients who received combined autologous stem cell therapy: in spinal cord and skeletal muscle

Muscular Trophism and voluntary contractile capacity improvement after intramuscular implant of autologous muscular progenitor cells in SCI patients

Combined treatment: cellular therapy and rehabilitation for chronic SCI patients. Final results phase I-II clinical trial

Intramuscular cell implant in muscles with electromyography recovery in SCI patients previously treated with neural progenitor cells and intensive rehabilitation

Results of a Nobel Neurorehabilitation program applied in 8 chronic and complete SCI patients treated with Autologous neural stem cell

Use of electromyography to evaluate recovery in patients with chronic and complete spinal cord injury who received combined therapy: Neurorehabilitation and Autologous Neural Stem Cell implant

Outcomes in 8 chronic and complete spinal cord injury patients after 30 months of combined therapy: neurorehabilitation and autologous neural stem cell implant

Electromyographic changes observed after combined treatment: autologous stem cell implant and intensive rehabilitation in patients with complete, chronic SCI

Combined cell therapy for complete chronic Spinal Cord Injury (cSCI) patients. Response after one year of treatment

Adipose Mesenquimal stromal Cells as a base of combined cell therapy for chronic spinal cord injury patients. Clinical ALD electrophysiological response after six month of treatment

Surface Electromyography study of complete Spinal Cord Injury Patients. Preliminary Results

Neurorehabilitation after cellular therapy for chronic spinal cord injury patients. 16th Congress of the European Federation of Neurological Societies

Functional changes in patient with Transverse Myelitis of 20 years of evolution alter administering combined therapy: autologous neuroblasts implant and intensive neurorehabilitation. Maimónides University, Buenos Aires- Argentina

Minimal Invasive Neural Stem Cell (NSC) Implant Associated with Autologous Effector T Cell (ETC) Treatment for Spinal Cord Injury (SCI) Patients

Effect of Minimal Invasive Neural Stem Cell (NSC) Implant Associated with Autologous Effector T Cell (ETC) Treatment on Severe Brain Injured (BI) Patients